Використання методів машинного навчання в сучасній математичній онкології
Анотація
Мета роботи: виконати аналіз сучасних підходів до оцінки ефективності та безпеки препаратів антиракової терапії із застосуванням методів машинного навчання, а також визначити перспективи їхнього використання у сучасній математичній онкології, в онкологічних дослідженнях, які широко використовують математичне моделювання та комп’ютерні симуляції.
Методи дослідження: пошук та аналіз сучасних наукових публікацій, які стосуються тематики використання машинного навчання в онкології.
В результаті дослідження було зроблено систематичний огляд літератури за тематикою використання машинного навчання в онкології. Було виконано аналіз використання основних методів машинного навчання, таких як метод контрольованого навчання (Supervised Learning, SL), метод неконтрольованого навчання (Unsupervised Learning, UL) та метод навчання з підкріпленням (Reinforcement Learning, RL) у сучасній онкології. Наведено приклади використання різноманітних алгоритмів машинного навчання у дослідженнях, які пов’язані з антираковою терапією та онкологією взагалі. Проаналізовані переваги та недоліки використаних алгоритмів машинного навчання в залежності від задач, які потрібно вирішити.
Висновки: Методи машинного навчання вже досить широко використовуються в медичних дослідженнях в сфері онкології. Вони успішно застосовувались для вирішення багатьох питань та показували гарні результати, але існує ще багато напрямків в онкології в яких використання методів машинного навчання може принести значний вклад в покращення медичних досліджень та медичної допомоги при лікуванні онкологічних захворювань. Наприклад, дуже перспективним виглядає використання алгоритмів, які засновані на навчанні з підкріпленням в персоналізованій прецензійній медицині, методи якої займають значну роль в персоналізованому лікуванні онкологічних захворювань.
Завантаження
Посилання
/Посилання
F. Bray, M. Laversanne, H. Sung, J. Ferlay, R.L. Siegel, I. Soerjomataram, A. Jemal, “Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries”, Cancer Journal for Clinicians.;74:229–263, 2024. DOI: 10.3322/caac.21834
Global cancer observatory: website. URL: https://gco.iarc.who.int (accessed 12.05.2025)
W.D. Hazelton, E. G. Luebeck, “Biomarker-based early cancer detection: Is it achievable?”, Sci Transl Med;3(109):109fs9, 2011. DOI: 10.1126/scitranslmed.300327
C.D. de los Rios de la Serna, C.B. Boers-Doets, T. Wiseman, B. Radia, R. Hammond, “Early Recognition and Management of Side Effects Related to Systemic Anticancer Therapy for Advanced Breast Cancer”, Seminars in Oncology Nursing, 40, 151553, 2024. https://doi.org/10.1016/j.soncn.2023.151553
J.A. DiMasi, H.G. Grabowski, R.W. Hansen, “Innovation in the pharmaceutical industry: new estimates of R&D costs”, Journal Health Econ, 47 20–33, 2016. doi: 10.1016/j.jhealeco.2016.01.012
M. Nilashi, H. Ahmadi, R.A. Abumalloh, M. Alrizq, A. Alghamdi, S. Alyami, “Knowledge Discovery of Patients Reviews on Breast Cancer Drugs: Segmentation of Side Effects Using Machine Learning Techniques Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity”, Artificial Intelligence Chemistry 1, 100011, 2023. https://doi.org/10.1016/j.aichem.2023.100011
S. Yang, S. Kar. Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity, 2023, USA https://doi.org/10.1016/j.aichem.2023.100011
R. P. Riechelmann, C. Zimmermann, S. N. Chin, L. Wang, A. O’Carroll, S. Zarinehbaf, “Potential drug interactions in cancer patients receiving supportive care exclusively”, Journal of Pain and Symptom Management, 35(5), 535–543, 2008. doi: 10.1016/j.jpainsymman.2007.06.009
J. Sultana, P. Cutroneo, G. Trifiro, “Clinical and economic burden of adverse drug reactions”, Journal Pharmacol Pharmacother, 4, 73–77, 2013. doi: 10.4103/0976-500X.120957
A. Bhandari, B. Gu, F.M. Kashkooli, W. “Zhan Image-based predictive modelling frameworks for personalised drug delivery in cancer therapy” Journal of Controlled Release, 370, 721–746, 2024. https://doi.org/10.1016/j.jconrel.2024.05.004
R. C. Rockne , J. G. Scott, “Introduction to Mathematical Oncology” JCO Clin Cancer Inform. 3:CCI.19.00357, Apr 26, 2019. doi: 10.1200/CCI.19.00010
F. Firoozbakht, B. Yousefi, B. Schwikowski, “An overview of machine learning methods for monotherapy drug response prediction”, Briefings in Bioinformatics, pp.bbab408, 2021. doi: 10.1093/bib/bbab408. hal-03376028
O. Teplytska, M. Ernst, L.M. Koltermann, D. Valderrama, E. Trunz, M. Vaisband, J. Hasenauer, H. Fröhlich, H. Jaehde Machine, “Learning Methods for Precision Dosing in Anticancer Drug Therapy: A Scoping Review”, Clinical Pharmacokinetics 63:1221–1237, 2024. doi:10.1007/s40262-024-01409-9
T. Eguale, D.L. Buckeridge, A.Verma, N.E. Winslade, A.Benedetti, J.A. Hanley, “Association of off-label drug use and adverse drug events in an adult population”, JAMA Internal Medicine, 176(1), 55–63, 2016. doi: 10.1001/jamainternmed.2015.6058.
S. Guan, G. Wang, “Drug discovery and development in the era of artificial intelligence: From machine learning to large language models”, Artificial Intelligence Chemistry, 2, 100070, 2024. https://doi.org/10.1016/j.aichem.2024.100070
J. Liu, M. Li, X. Chen, “AntiMF: A deep learning framework for predicting anticancer peptides based on multi-view feature extraction”, Methods, 207, 38–43, 2022. https://doi.org/10.1016/j.ymeth.2022.07.017
L.T. Phan, H.W. Park, T. Pitti, T. Madhavan, Y.-J. Jeon, B. Manavalan, “MLACP 2.0: An updated machine learning tool for anticancer peptide prediction”, Computational and Structural Biotechnology Journal, 20, 4473–4480, 2022. doi:10.1016/j.csbj.2022.07.043
B.A. Badwan, G. Liaropoulos, E. Kyrodimos, D. Skaltsas, A. Tsirigos, V.G. Gorgoulis, “Machine learning approaches to predict drug efficacy and toxicity in oncology”, Reports Methods, 3, 100413, 2023. doi:10.1016/j.crmeth.2023.100413
A. Partin, T.S. Brettin, Y. Zhu, O. Narykov, A. Clyde, J. Overbeek and R.L. Stevens, “Deep learning methods for drug response prediction in cancer: Predominant and emerging trends”, Front. Med. 10:1086097, 2023. doi: 10.3389/fmed.2023.1086097
K. Fan, L. Cheng, L. Li, “Artificial intelligence and machine learning methods in predicting anti-cancer drug combination effects”, Briefings in Bioinformatics, 22(6), 1–12, 2021. https://doi.org/10.1093/bib/bbab271
S. She, H. Chen, W. Ji, M. Sun, J. Cheng, C. RuiMand Feng, “Deep learning based multi-drug synergy prediction model for individually tailored anticancer therapies”, Front. Pharmacol. 13:1032875, 2022. doi: 10.3389/fphar.2022.1032875
R. Rafique, S.M.R. Islam, J.U. Kazi, “Machine learning in the prediction of cancer therapy”, Computational and Structural Biotechnology Journal, 19, 4003–4017, 2021. doi.org/10.1016/j.csbj.2021.07.003
J.-B. Zhou, D. Tang, L. He, S. Lin, J.H. Lei, H. Sun, X. Xu, C.-X. Deng, “Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation”, Pharmacological Research, 194, 106830, 2023. doi:10.1016/j.phrs.2023.106830
W. Shan, C. Shen, L. Luo, P. Ding, “Multi-task learning for predicting synergistic drug combinations based on auto-encoding multirelational graphs”, iScience, 26, 108020, 2023. doi.org:10.1016/j.isci.2023.108020
M. Timilsina, M. Tandan, V. Nováček. “Machine learning approaches for predicting the onset time of the adverse drug events in oncology”, Machine Learning with Applications, 9, 100367, 2022. doi:10.1016/j.mlwa.2022.100367
M.S. Barakat, M. Field, A. Ghose, D. Stirling, L. Holloway, S. Vinod, “The effect of imputing missing clinical attribute values on training lung cancer survival prediction model performance”, Health Information Science and Systems, 5(1), 1–11, 2017. DOI:10.1007/s13755-017-0039-4
R. Kurilov, B. Haibe-Kains, B. Brors, “Assessment of modelling strategies for drug response prediction in cell lines and xenografts”, Sci Rep, 10:2849, 2020. DOI:10.1038/s41598-020-59656-2
T. Hastie, R. Tibshirani, J. Friedman, The elements of statistical learning data mining, inference, and prediction, New York, NY: Springer Science & Business Media, 2009.
Y. Li, D.M. Umbach, J.M. Krahn, “Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines”, BMC Genomics, 22:272, 2021. DOI:10.1186/s12864-021-07581-7
S. Nath, E. Korot, D.J. Fu, G. Zhang, K. Mishra, A.Y. Lee, “Reinforcement learning in ophthalmology: potential applications and challenges to implementation”, 4, E692-E697, September, 2022. DOI: 10.1016/S2589-7500(22)00128-5
A. Jonsson, “Deep reinforcement learning in medicine”, Kidney Dis. (Basel), 5(1):18–22, 2019. doi: 10.1159/000492670
C. Shen, D. Nguyen, L. Chen, Y. Gonzalez, R. McBeth, N. Qin, S. B. Jiang, and X. Jia, “Operating a treatment planning system using a deep-reinforcement learning-based virtual treatment planner for prostate cancer intensity-modulated radiation therapy treatment planning,” Medical physics, vol. 47, no. 6, pp. 2329–2336, 2020. DOI: 10.1002/mp.14114
I. Triguero, S. García, F.Herrera, “Self-labeled techniques for semi-supervised learning: taxonomy, software and empirical study”, Knowledge and Information Systems, 42 (2):245–84, 2015. DOI:10.1007/s10115-013-0706-y
C. S. Greene, J. Tan, M. Ung, J. H. Moore, C. Cheng, “Big Data Bioinformatics”, J Cell Physiol, 229(12):1896-900, Dec. 2014. DOI: 10.1002/jcp.24662
C. Cortes, V. Vapnik, “Support-vector networks”, Chemical Biology & Drug Design, 297(3):273-297, 2009. DOI:10.1007/%2FBF00994018
R.Tibshirani, “Regression shrinkage and selection via the Lasso”, Journal of the Royal Statistical Society Series B (Statistical Methodology), 73(3):273-282, 2011. DOI:10.2307/41262671
R. Rafique, S.M. Riazul Islam, J. U. Kazi, “Machine learning in the prediction of cancer therapy”, Comput Struct Biotechnol J, 8:19:4003-4017, Jul., 2021. DOI: 10.1016/j.csbj.2021.07.003
V. Podgorelec, P. Kokol, B. Stiglic, I.Rozman, “Decision trees: an overview and their use in medicine”, J. Med. Syst., 26:445–63, 2002. doi: 10.1023/a:1016409317640.
R.W. Tothill, A.V. Tinker, J. George, R. Brown, S.B. Fox, S. Lade, D.S. Johnson, M.K. Trivett, D. Etemadmoghadam, B. Locandro, N. Traficante, S. Fereday, J.A. Hung, Y.E. Chiew, I. Haviv, D. Gertig, A. DeFazio, D.D. Bowtell, “Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome”, Clin Cancer Res., 14:5198–5208, 2008. doi: 10.1158/1078-0432.CCR-08-0196.
L.Breiman, “Random forests”, Machine Learning, 45:5–32, 2001. DOI:10.1023/A:1010950718922
D. Bertsimas, H. Wiberg, “Machine Learning in Oncology: Methods, Applications, and Challenges”, JCO Clin Cancer Inform, 4:885-894, Oct. 2020. doi: 10.1200/CCI.20.00072.
J.-N. Eckardt, K. Wendt, M. Bornhäuser, J. M. Middeke, “Reinforcement Learning for Precision Oncology”, Cancers (Basel), 13(18):4624, Sep. 2021. doi: 10.3390/cancers13184624.
S. Van Buuren, Flexible imputation of missing data, CRC. Press, New York, NY, 2018
D. Pratap, Statistics for Machine Learning Build supervised, unsupervised, and reinforcement learning models using both Python and R., Birmingham, England, Packt, 2017.
R.G. Lopez, “Reinforcement Learning in Oncology: A Comprehensive Review”. 2023 https://studenttheses.uu.nl/handle/20.500.12932/47144
V. Mnih, K. Kavukcuoglu, D. Silver, “Human-level control through deep reinforcement learning”, Nature, 518(7540):529-33, Feb, 2015 DOI: 10.1038/nature14236
R. S. Sutton, A. Barto, Reinforcement learning: An introduction, MIT press, London, England, 2018.
C. Li, Y. Guo, X. Lin, X. Feng, D. Xu, R. Yang, “Deep reinforcement learning in radiation therapy planning optimization: A comprehensive review”, Phys Med, 125:104498, Sep, 2024. doi: 10.1016/j.ejmp.2024.104498.
M. Liu, X. Shen, W. Pan, ”Deep reinforcement learning for personalized treatment recommendation”, Stat Med, 41(20):4034-4056, Sep, 2022. doi: 10.1002/sim.9491.
J.S. Parker, M. Mullins, M.C.U. Cheang, S. Leung, D. Voduc, T. Vickery, “Supervised risk predictor of breast cancer based on intrinsic subtypes”, J. Clin. Oncol, 27(8):1160–7, 2009. doi: 10.1200/JCO.2008.18.1370
P. Geeleher, N.J. Cox, R. Huang, “Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines”, Genome Biol, 15(3):R47, 2014. doi: 10.1186/gb-2014-15-3-r47.
Y. Kim, D. Kim, B. Cao, R. Carvajal, M. Kim, ”PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients”, BMC Bioinformatics, 21(1):288, Jul, 2020. doi: 10.1186/s12859-020-03633-z.
J.H. Kong, H. Lee, D. Kim, S.K. Han, D. Ha, K. Shin, “Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients”, Nat Commun, 11(1):5485, Oct 2020. doi: 10.1038/s41467-020-19313-8.
M.P. Menden, F. Iorio, M. Garnett, U. McDermott, C.H. Benes, P.J. Ballester, “Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties”, PLoS One, 8(4):e61318, Apr 2013. doi: 10.1371/journal.pone.0061318. Print 2013.
Y. Chang, H. Park, H.J. Yang, S. Lee, K.Y. Lee, T.S. Kim, “Cancer Drug Response Profile scan (CDRscan): A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature”, Sci Rep, 8(1):8857, Jun 2018. doi: 10.1038/s41598-018-27214-6.
T. Sakellaropoulos, K. Vougas, S. Narang, F. Koinis, A. Kotsinas, A. Polyzos, “A Deep Learning Framework for Predicting Response to Therapy in Cancer”, Cell Rep, 29(11):3367-3373.e4, Dec, 2019. doi: 10.1016/j.celrep.2019.11.017..
A. Malyutina, M.M. Majumder, W. Wang, A. Pessia, C.A. Heckman, J.Tang, “Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer”, PLoS Comput Biol, 15(5):e1006752, May, 2019. doi: 10.1371/journal.pcbi.1006752
M. Ammad-Ud-Din, S.A. Khan, K. Wennerberg, T. Aittokallio, “Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression”, Bioinformatics, 33(14):i359-i368, Jul 2017. doi: 10.1093/bioinformatics/btx266.
T. Zhang, L. Zhang, P.R.O. Payne, F. Li, “Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models”, Methods Mol Biol, 2194:223-238, 2021. doi: 10.1007/978-1-0716-0849-4_12.
K.-H.Yu, A.L. Beam, I.S. Kohane, “Artificial Intelligence in Healthcare”, Nat Biomed Eng, 2(10):719-731, Oct, 2018. doi: 10.1038/s41551-018-0305-z.
J. Wang, J. Miao, X. Yang, R. Li, G. Zhou, Y. Huang, Z. Lin, W. Xue, X. Jia, J. Zhou, “Auto-weighting for breast cancer classification in multimodal ultrasound”, Springer, Part VI 23, pp. 190–199, 2020. DOI:10.48550/arXiv.2008.03435
F. E. Alsaadi, A. Yasami, C. Volos, S. Bekiros, and H. Jahanshahi, “A new fuzzy reinforcement learning method for effective chemotherapy”, Mathematics, vol. 11, no. 2, p. 477, 2023. DOI:10.3390/math11020477
C. Xu, Y. Song, D. Zhang, L. K. Bittencourt, S. H. Tirumani, and S. Li, “Spatiotemporal knowledge teacher–student reinforcement learning to detect liver tumors without contrast agents”, Medical Image Analysis, vol. 90, p. 102 980, 2023. doi: 10.1016/j.media.2023.102980.
C. Shen, D. Nguyen, L. Chen, Y. Gonzalez, R. McBeth, N. Qin, S. B. Jiang, and X. Jia, “Operating a treatment planning system using a deep-reinforcement learning-based virtual treatment planner for prostate cancer intensity-modulated radiation therapy treatment planning”, Medical physics, vol. 47, no. 6, pp. 2329–2336, 2020. doi: 10.1002/mp.14114.
A. Ebrahimi Zade, S. Shahabi Haghighi, M. Soltani, “Reinforcement Learning for Optimal Scheduling of Glioblastoma Treatment with Temozolomide”, Comput Methods Programs Biomed, 193:105443, Sep 2020. doi: 10.1016/j.cmpb.2020.105443
F. Bray, M. Laversanne, H. Sung, J. Ferlay, R.L. Siegel, I. Soerjomataram, A. Jemal, “Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries”, Cancer Journal for Clinicians.;74:229–263, 2024. DOI: 10.3322/caac.21834
Global cancer observatory: website. URL: https://gco.iarc.who.int (accessed 12.05.2025)
W.D. Hazelton, E. G. Luebeck, “Biomarker-based early cancer detection: Is it achievable?”, Sci Transl Med;3(109):109fs9, 2011. DOI: 10.1126/scitranslmed.300327
C.D. de los Rios de la Serna, C.B. Boers-Doets, T. Wiseman, B. Radia, R. Hammond, “Early Recognition and Management of Side Effects Related to Systemic Anticancer Therapy for Advanced Breast Cancer”, Seminars in Oncology Nursing, 40, 151553, 2024. https://doi.org/10.1016/j.soncn.2023.151553
J.A. DiMasi, H.G. Grabowski, R.W. Hansen, “Innovation in the pharmaceutical industry: new estimates of R&D costs”, Journal Health Econ, 47 20–33, 2016. doi: 10.1016/j.jhealeco.2016.01.012
M. Nilashi, H. Ahmadi, R.A. Abumalloh, M. Alrizq, A. Alghamdi, S. Alyami, “Knowledge Discovery of Patients Reviews on Breast Cancer Drugs: Segmentation of Side Effects Using Machine Learning Techniques Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity”, Artificial Intelligence Chemistry 1, 100011, 2023. https://doi.org/10.1016/j.aichem.2023.100011
S. Yang, S. Kar. Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity, 2023, USA https://doi.org/10.1016/j.aichem.2023.100011
R. P. Riechelmann, C. Zimmermann, S. N. Chin, L. Wang, A. O’Carroll, S. Zarinehbaf, “Potential drug interactions in cancer patients receiving supportive care exclusively”, Journal of Pain and Symptom Management, 35(5), 535–543, 2008. doi: 10.1016/j.jpainsymman.2007.06.009
J. Sultana, P. Cutroneo, G. Trifiro, “Clinical and economic burden of adverse drug reactions”, Journal Pharmacol Pharmacother, 4, 73–77, 2013. doi: 10.4103/0976-500X.120957
A. Bhandari, B. Gu, F.M. Kashkooli, W. “Zhan Image-based predictive modelling frameworks for personalised drug delivery in cancer therapy” Journal of Controlled Release, 370, 721–746, 2024. https://doi.org/10.1016/j.jconrel.2024.05.004
R. C. Rockne , J. G. Scott, “Introduction to Mathematical Oncology” JCO Clin Cancer Inform. 3:CCI.19.00357, Apr 26, 2019. doi: 10.1200/CCI.19.00010
F. Firoozbakht, B. Yousefi, B. Schwikowski, “An overview of machine learning methods for monotherapy drug response prediction”, Briefings in Bioinformatics, pp.bbab408, 2021. doi: 10.1093/bib/bbab408. hal-03376028
O. Teplytska, M. Ernst, L.M. Koltermann, D. Valderrama, E. Trunz, M. Vaisband, J. Hasenauer, H. Fröhlich, H. Jaehde Machine, “Learning Methods for Precision Dosing in Anticancer Drug Therapy: A Scoping Review”, Clinical Pharmacokinetics 63:1221–1237, 2024. doi:10.1007/s40262-024-01409-9
T. Eguale, D.L. Buckeridge, A.Verma, N.E. Winslade, A.Benedetti, J.A. Hanley, “Association of off-label drug use and adverse drug events in an adult population”, JAMA Internal Medicine, 176(1), 55–63, 2016. doi: 10.1001/jamainternmed.2015.6058.
S. Guan, G. Wang, “Drug discovery and development in the era of artificial intelligence: From machine learning to large language models”, Artificial Intelligence Chemistry, 2, 100070, 2024. https://doi.org/10.1016/j.aichem.2024.100070
J. Liu, M. Li, X. Chen, “AntiMF: A deep learning framework for predicting anticancer peptides based on multi-view feature extraction”, Methods, 207, 38–43, 2022. https://doi.org/10.1016/j.ymeth.2022.07.017
L.T. Phan, H.W. Park, T. Pitti, T. Madhavan, Y.-J. Jeon, B. Manavalan, “MLACP 2.0: An updated machine learning tool for anticancer peptide prediction”, Computational and Structural Biotechnology Journal, 20, 4473–4480, 2022. doi:10.1016/j.csbj.2022.07.043
B.A. Badwan, G. Liaropoulos, E. Kyrodimos, D. Skaltsas, A. Tsirigos, V.G. Gorgoulis, “Machine learning approaches to predict drug efficacy and toxicity in oncology”, Reports Methods, 3, 100413, 2023. doi:10.1016/j.crmeth.2023.100413
A. Partin, T.S. Brettin, Y. Zhu, O. Narykov, A. Clyde, J. Overbeek and R.L. Stevens, “Deep learning methods for drug response prediction in cancer: Predominant and emerging trends”, Front. Med. 10:1086097, 2023. doi: 10.3389/fmed.2023.1086097
K. Fan, L. Cheng, L. Li, “Artificial intelligence and machine learning methods in predicting anti-cancer drug combination effects”, Briefings in Bioinformatics, 22(6), 1–12, 2021. https://doi.org/10.1093/bib/bbab271
S. She, H. Chen, W. Ji, M. Sun, J. Cheng, C. RuiMand Feng, “Deep learning based multi-drug synergy prediction model for individually tailored anticancer therapies”, Front. Pharmacol. 13:1032875, 2022. doi: 10.3389/fphar.2022.1032875
R. Rafique, S.M.R. Islam, J.U. Kazi, “Machine learning in the prediction of cancer therapy”, Computational and Structural Biotechnology Journal, 19, 4003–4017, 2021. doi.org/10.1016/j.csbj.2021.07.003
J.-B. Zhou, D. Tang, L. He, S. Lin, J.H. Lei, H. Sun, X. Xu, C.-X. Deng, “Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation”, Pharmacological Research, 194, 106830, 2023. doi:10.1016/j.phrs.2023.106830
W. Shan, C. Shen, L. Luo, P. Ding, “Multi-task learning for predicting synergistic drug combinations based on auto-encoding multirelational graphs”, iScience, 26, 108020, 2023. doi.org:10.1016/j.isci.2023.108020
M. Timilsina, M. Tandan, V. Nováček. “Machine learning approaches for predicting the onset time of the adverse drug events in oncology”, Machine Learning with Applications, 9, 100367, 2022. doi:10.1016/j.mlwa.2022.100367
M.S. Barakat, M. Field, A. Ghose, D. Stirling, L. Holloway, S. Vinod, “The effect of imputing missing clinical attribute values on training lung cancer survival prediction model performance”, Health Information Science and Systems, 5(1), 1–11, 2017. DOI:10.1007/s13755-017-0039-4
R. Kurilov, B. Haibe-Kains, B. Brors, “Assessment of modelling strategies for drug response prediction in cell lines and xenografts”, Sci Rep, 10:2849, 2020. DOI:10.1038/s41598-020-59656-2
T. Hastie, R. Tibshirani, J. Friedman, The elements of statistical learning data mining, inference, and prediction, New York, NY: Springer Science & Business Media, 2009.
Y. Li, D.M. Umbach, J.M. Krahn, “Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines”, BMC Genomics, 22:272, 2021. DOI:10.1186/s12864-021-07581-7
S. Nath, E. Korot, D.J. Fu, G. Zhang, K. Mishra, A.Y. Lee, “Reinforcement learning in ophthalmology: potential applications and challenges to implementation”, 4, E692-E697, September, 2022. DOI: 10.1016/S2589-7500(22)00128-5
A. Jonsson, “Deep reinforcement learning in medicine”, Kidney Dis. (Basel), 5(1):18–22, 2019. doi: 10.1159/000492670
C. Shen, D. Nguyen, L. Chen, Y. Gonzalez, R. McBeth, N. Qin, S. B. Jiang, and X. Jia, “Operating a treatment planning system using a deep-reinforcement learning-based virtual treatment planner for prostate cancer intensity-modulated radiation therapy treatment planning,” Medical physics, vol. 47, no. 6, pp. 2329–2336, 2020. DOI: 10.1002/mp.14114
I. Triguero, S. García, F.Herrera, “Self-labeled techniques for semi-supervised learning: taxonomy, software and empirical study”, Knowledge and Information Systems, 42 (2):245–84, 2015. DOI:10.1007/s10115-013-0706-y
C. S. Greene, J. Tan, M. Ung, J. H. Moore, C. Cheng, “Big Data Bioinformatics”, J Cell Physiol, 229(12):1896-900, Dec. 2014. DOI: 10.1002/jcp.24662
C. Cortes, V. Vapnik, “Support-vector networks”, Chemical Biology & Drug Design, 297(3):273-297, 2009. DOI:10.1007/%2FBF00994018
R.Tibshirani, “Regression shrinkage and selection via the Lasso”, Journal of the Royal Statistical Society Series B (Statistical Methodology), 73(3):273-282, 2011. DOI:10.2307/41262671
R. Rafique, S.M. Riazul Islam, J. U. Kazi, “Machine learning in the prediction of cancer therapy”, Comput Struct Biotechnol J, 8:19:4003-4017, Jul., 2021. DOI: 10.1016/j.csbj.2021.07.003
V. Podgorelec, P. Kokol, B. Stiglic, I.Rozman, “Decision trees: an overview and their use in medicine”, J. Med. Syst., 26:445–63, 2002. doi: 10.1023/a:1016409317640.
R.W. Tothill, A.V. Tinker, J. George, R. Brown, S.B. Fox, S. Lade, D.S. Johnson, M.K. Trivett, D. Etemadmoghadam, B. Locandro, N. Traficante, S. Fereday, J.A. Hung, Y.E. Chiew, I. Haviv, D. Gertig, A. DeFazio, D.D. Bowtell, “Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome”, Clin Cancer Res., 14:5198–5208, 2008. doi: 10.1158/1078-0432.CCR-08-0196.
L.Breiman, “Random forests”, Machine Learning, 45:5–32, 2001. DOI:10.1023/A:1010950718922
D. Bertsimas, H. Wiberg, “Machine Learning in Oncology: Methods, Applications, and Challenges”, JCO Clin Cancer Inform, 4:885-894, Oct. 2020. doi: 10.1200/CCI.20.00072.
J.-N. Eckardt, K. Wendt, M. Bornhäuser, J. M. Middeke, “Reinforcement Learning for Precision Oncology”, Cancers (Basel), 13(18):4624, Sep. 2021. doi: 10.3390/cancers13184624.
S. Van Buuren, Flexible imputation of missing data, CRC. Press, New York, NY, 2018
D. Pratap, Statistics for Machine Learning Build supervised, unsupervised, and reinforcement learning models using both Python and R., Birmingham, England, Packt, 2017.
R.G. Lopez, “Reinforcement Learning in Oncology: A Comprehensive Review”. 2023 https://studenttheses.uu.nl/handle/20.500.12932/47144
V. Mnih, K. Kavukcuoglu, D. Silver, “Human-level control through deep reinforcement learning”, Nature, 518(7540):529-33, Feb, 2015 DOI: 10.1038/nature14236
R. S. Sutton, A. Barto, Reinforcement learning: An introduction, MIT press, London, England, 2018.
C. Li, Y. Guo, X. Lin, X. Feng, D. Xu, R. Yang, “Deep reinforcement learning in radiation therapy planning optimization: A comprehensive review”, Phys Med, 125:104498, Sep, 2024. doi: 10.1016/j.ejmp.2024.104498.
M. Liu, X. Shen, W. Pan, ”Deep reinforcement learning for personalized treatment recommendation”, Stat Med, 41(20):4034-4056, Sep, 2022. doi: 10.1002/sim.9491.
J.S. Parker, M. Mullins, M.C.U. Cheang, S. Leung, D. Voduc, T. Vickery, “Supervised risk predictor of breast cancer based on intrinsic subtypes”, J. Clin. Oncol, 27(8):1160–7, 2009. doi: 10.1200/JCO.2008.18.1370
P. Geeleher, N.J. Cox, R. Huang, “Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines”, Genome Biol, 15(3):R47, 2014. doi: 10.1186/gb-2014-15-3-r47.
Y. Kim, D. Kim, B. Cao, R. Carvajal, M. Kim, ”PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients”, BMC Bioinformatics, 21(1):288, Jul, 2020. doi: 10.1186/s12859-020-03633-z.
J.H. Kong, H. Lee, D. Kim, S.K. Han, D. Ha, K. Shin, “Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients”, Nat Commun, 11(1):5485, Oct 2020. doi: 10.1038/s41467-020-19313-8.
M.P. Menden, F. Iorio, M. Garnett, U. McDermott, C.H. Benes, P.J. Ballester, “Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties”, PLoS One, 8(4):e61318, Apr 2013. doi: 10.1371/journal.pone.0061318. Print 2013.
Y. Chang, H. Park, H.J. Yang, S. Lee, K.Y. Lee, T.S. Kim, “Cancer Drug Response Profile scan (CDRscan): A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature”, Sci Rep, 8(1):8857, Jun 2018. doi: 10.1038/s41598-018-27214-6.
T. Sakellaropoulos, K. Vougas, S. Narang, F. Koinis, A. Kotsinas, A. Polyzos, “A Deep Learning Framework for Predicting Response to Therapy in Cancer”, Cell Rep, 29(11):3367-3373.e4, Dec, 2019. doi: 10.1016/j.celrep.2019.11.017..
A. Malyutina, M.M. Majumder, W. Wang, A. Pessia, C.A. Heckman, J.Tang, “Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer”, PLoS Comput Biol, 15(5):e1006752, May, 2019. doi: 10.1371/journal.pcbi.1006752
M. Ammad-Ud-Din, S.A. Khan, K. Wennerberg, T. Aittokallio, “Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression”, Bioinformatics, 33(14):i359-i368, Jul 2017. doi: 10.1093/bioinformatics/btx266.
T. Zhang, L. Zhang, P.R.O. Payne, F. Li, “Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models”, Methods Mol Biol, 2194:223-238, 2021. doi: 10.1007/978-1-0716-0849-4_12.
K.-H.Yu, A.L. Beam, I.S. Kohane, “Artificial Intelligence in Healthcare”, Nat Biomed Eng, 2(10):719-731, Oct, 2018. doi: 10.1038/s41551-018-0305-z.
J. Wang, J. Miao, X. Yang, R. Li, G. Zhou, Y. Huang, Z. Lin, W. Xue, X. Jia, J. Zhou, “Auto-weighting for breast cancer classification in multimodal ultrasound”, Springer, Part VI 23, pp. 190–199, 2020. DOI:10.48550/arXiv.2008.03435
F. E. Alsaadi, A. Yasami, C. Volos, S. Bekiros, and H. Jahanshahi, “A new fuzzy reinforcement learning method for effective chemotherapy”, Mathematics, vol. 11, no. 2, p. 477, 2023. DOI:10.3390/math11020477
C. Xu, Y. Song, D. Zhang, L. K. Bittencourt, S. H. Tirumani, and S. Li, “Spatiotemporal knowledge teacher–student reinforcement learning to detect liver tumors without contrast agents”, Medical Image Analysis, vol. 90, p. 102 980, 2023. doi: 10.1016/j.media.2023.102980.
C. Shen, D. Nguyen, L. Chen, Y. Gonzalez, R. McBeth, N. Qin, S. B. Jiang, and X. Jia, “Operating a treatment planning system using a deep-reinforcement learning-based virtual treatment planner for prostate cancer intensity-modulated radiation therapy treatment planning”, Medical physics, vol. 47, no. 6, pp. 2329–2336, 2020. doi: 10.1002/mp.14114.
A. Ebrahimi Zade, S. Shahabi Haghighi, M. Soltani, “Reinforcement Learning for Optimal Scheduling of Glioblastoma Treatment with Temozolomide”, Comput Methods Programs Biomed, 193:105443, Sep 2020. doi: 10.1016/j.cmpb.2020.105443